Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations.
Balabanski L, Serbezov D, Nikolova D, Antonova O, Nesheva D, Hammoudeh Z, Vazharova R, Karachanak-Yankova S, Staneva R, Mihaylova M, Damyanova V, Hadjidekova S, Toncheva D.
Balabanski L, et al. Among authors: serbezov d.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820911082. doi: 10.1177/1533033820911082.
Technol Cancer Res Treat. 2020.
PMID: 32233832
Free PMC article.